Intuitive Surgical, Inc. $ISRG Stock Position Lifted by Intellectus Partners LLC

Intellectus Partners LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.5% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,545 shares of the medical equipment provider’s stock after purchasing an additional 155 shares during the period. Intellectus Partners LLC’s holdings in Intuitive Surgical were worth $2,470,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Vanguard Group Inc. grew its position in Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after acquiring an additional 453,335 shares in the last quarter. Invesco Ltd. grew its position in Intuitive Surgical by 1.7% in the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after acquiring an additional 71,794 shares in the last quarter. Northern Trust Corp grew its position in Intuitive Surgical by 0.3% in the first quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after acquiring an additional 11,988 shares in the last quarter. Wellington Management Group LLP grew its position in Intuitive Surgical by 15.0% in the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after acquiring an additional 457,080 shares in the last quarter. Finally, Nuveen LLC bought a new stake in Intuitive Surgical in the first quarter worth approximately $1,715,899,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Daiwa Capital Markets upped their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a report on Friday, October 24th. Royal Bank Of Canada set a $625.00 price objective on shares of Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Evercore ISI upped their price objective on shares of Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Finally, Robert W. Baird set a $655.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $608.92.

Intuitive Surgical Stock Up 0.8%

NASDAQ:ISRG opened at $534.28 on Monday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The firm has a market capitalization of $191.53 billion, a PE ratio of 70.67, a price-to-earnings-growth ratio of 4.94 and a beta of 1.61. The firm has a 50-day moving average price of $464.32 and a 200 day moving average price of $498.73.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the prior year, the business posted $1.84 earnings per share. The company’s quarterly revenue was up 22.9% compared to the same quarter last year. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, Director Amy L. Ladd sold 336 shares of the stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 96,011 shares of company stock valued at $50,309,042. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.